- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02463474
Mobile Health (mHealth) Black Women With Breast Cancer
Piloting the Acceptability of a Culturally Tailored Evidence-Based mHealth Intervention for Low-Income Black Women With Breast Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Though Black women have a lower breast cancer rate than White women, Black women have the poorest outcomes of all races and ethnicities. Low cancer knowledge and mistrust of the healthcare system have been shown to lead to poorer outcomes following breast cancer diagnosis. Participants are asked to be in this research study if they are a woman age 21 years or older who identifies as Black/ African American and has been diagnosed with breast cancer within the past 6 months.
First, participants will come to a pre-intervention study appointment and will be asked to complete several questionnaires. The questionnaires will ask about breast cancer knowledge, quality of life, and their relationship with their doctor. Participants will then opt-in to the study by sending a text message to the study.
For the next ten ten weeks, participants will receive a text message with a link to one video clip per week. Each video is 15-20 minutes long and contains information about breast cancer. Participants will also receive one supportive text message per week for ten weeks.
At the end of the ten weeks, participants will be scheduled for a follow-up appointment. Participants will again be asked questions about breast cancer knowledge, quality of life, and their relationship with their doctor. Participants will also be asked what was helpful and not helpful about the videos.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- UF Health Shands Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 21 years or older
- Race/Ethnicity: Black from any cultural background (e.g., African American, Caribbean Islander, Haitian, Black Hispanic, etc.)
- Diagnosed with breast cancer stages 0-III in the past 6 months
- Life Expectancy: ≥12 months
- Income: at or below 200% of the federal poverty line
- Have access to a cellphone
- Able to receive text messages on cell phone
- Able to view video clips on cell phone.
Exclusion Criteria:
- Previous diagnosis of any type of cancer
- Conditions or behaviors likely to affect the conduct of the trial: unwilling or unable to give informed consent; unable to understand spoken English at the 8th grade level; unwilling to travel to University of Florida Health Shands hospital or HealthStreet for baseline and follow-up assessment appointments; inpatient psychiatric treatment for major psychiatric disorder in the past year; substance use disorder in the past year; and other conditions which in the opinion of study staff would adversely affect participation in the trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: mHealth Intervention
Each week for 10 weeks, participants will receive two text messages on their cell phone.
The first text message will contain a link to a culturally tailored, informational video clip about living with breast cancer.
The second text message that provides a supportive message about the video content.
|
Ten, short, engaging, entertaining and culturally relevant videos delivered to participants' cell phones provide breast cancer health information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breast Cancer Knowledge
Time Frame: Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
Breast cancer knowledge will be assessed using the Knowledge subscales of the Breast Cancer Surgery Decision Quality Instrument, short version 2 (BCS-DQI, SV2) developed by Massachusetts General Hospital.
The knowledge subscale has twelve multiple choice or fill in the blank items about breast cancer, treatment options, recurrence, survival and side effects.
|
Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Involvement in Care Scale
Time Frame: Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
The Perceived Involvement in Care Scale (PICS) is a 13 item self-report scale that assesses patient's perception of doctor and patient behaviors that occur during a medical visit.
It assesses the patients' perception of the doctors' facilitation of patient involvement, amount of information exchanged between the patient and doctor, and patient involvement in decision making.
|
Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
|
Perceived Stress Scale
Time Frame: Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
The Perceived Stress Scale (PSS) is a 10-item, self-report questionnaire of globally perceived stress.
Each item is rated for the past month on a 5-point Likert scale (1 = never to 5 = very often).
A higher total score indicates greater stress.
|
Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
|
Functional Assessment of Cancer Therapy-Breast (FACT-B)
Time Frame: Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
This questionnaire is a global measure of quality of life.
The FACT-B assesses well-being across five broad domains (i.e., physical, spiritual, social/family, emotional, and functional) and one specific domain of breast cancer symptoms.
The instructions ask participants to indicate to what degree each statement has been "true" during the past seven days.
|
Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
|
Acceptability
Time Frame: Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
This questionnaire queries the participant's ratings of the acceptability of the program.
Item content includes: program was a good use of my time, program was helpful, program will be useful in my daily life, program has helped me deal with my breast cancer, likeability of of the interventionist, acceptability of mobile health (mhealth) format, perceived skill of interventionist, ease of participation in intervention, interactions with program staff, ease of trouble shooting difficulties and overall rating
|
Baseline assessment (Week 1) to post-intervention assessment (Week 10)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nicole Ennis Whitehead, PhD, University of Florida
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201401002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Neoplasms
-
Emory UniversityEisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, BreastUnited States
-
National Cancer Institute (NCI)Not yet recruitingBreast Cancer | Breast Carcinoma | Malignant Neoplasm of Breast | Cancer of the BreastUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Massachusetts General HospitalMassachusetts Institute of TechnologyNot yet recruitingBreast Cancer | Breast Asymmetry | Breast Abnormalities | Breast LesionUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLCCompletedMale Breast Cancer | Breast - FemaleUnited States
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastUnited States
Clinical Trials on mHealth Intervention
-
Fatima Jinnah Women UniversityNot yet recruitingType 2 Diabetes Risk Reduction in Young AdultsPakistan
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; Kwong Wah Hospital; University of Glasgow; Tsan Yuk...RecruitingQuality of Life | Family Relations | Postnatal DepressionHong Kong
-
University of CadizAndalusian Health ServiceRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI); Ohio UniversityRecruitingMelanoma | Breast Cancer | Multiple Myeloma | Lung Cancer | Prostate CancerUnited States
-
Children's National Research InstituteRecruitingSexually Transmitted DiseasesUnited States
-
Kaiser PermanenteCompletedSmoking | Smoking CessationUnited States
-
KU LeuvenJomo Kenyatta University of Agriculture and TechnologyCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Completed
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Northwell Health, Early Treatment... and other collaboratorsCompletedSchizophrenia | First-Episode PsychosisUnited States
-
University of OklahomaCompletedChild Abuse | Parenting | Child Development | Child NeglectUnited States